当前位置：首页 > 文献互助 > 互助详情

期刊论文New Oral PCSK9 Inhibitor: “MK-0616”复制

用户aKgJC6g3RnhA 1小时前 9 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-03-07 09:55:19 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1097/CRD.0000000000000655复制

文献链接: https://journals.lww.com/10.1097/CRD.0000000000000655复制

其他信息:

出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Zoya Siddiqui; William Frishman

上一篇：MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment

下一篇：高级别脑膜瘤新药临床开发的中国专家共识

互助时间线

2026-02-28 10:03:04 [完结求助]

楼主确认了疯狂小猫应助的文件是正确的, 求助状态变成已完结

2026-02-28 09:55:19 [上传文件]

疯狂小猫上传了文件(pdf 636.49 KB), 求助状态变成待确认

2026-02-28 09:55:06 [发起求助]

最新发布的求助

Flash floods: why are more of them devastating the world’s driest regions? 5分钟前

Developing a machine learning model for detecting depression, anxiety, and apathy in older adults with mild cognitive impairment using speech and facial expressions: A cross-sectional observational study 8分钟前

Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids 22分钟前

Comparison of uptake of CardioPET, a potential PET tracer for myocardial fatty acid utilization and BFPET, a possible PET blood flow marker in fed vs fasted mice 27分钟前

Using circular dichroism spectra to estimate protein secondary structure 39分钟前

A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors 1小时前

Discovery of novel and potent 2-aminopyrazine-based HPK1 inhibitors enhancing T-cell immunity against cancer 1小时前

高级别脑膜瘤新药临床开发的中国专家共识 1小时前

New Oral PCSK9 Inhibitor: “MK-0616” 1小时前

MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment 1小时前

CD44 is associated with papillary thyroid carcinoma metastasis via potential modulation of the immunosuppressive tumor microenvironment 2小时前

FB-7013: A Novel, Long-Duration siRNA Targeting Mannan-Binding Lectin Serine Protease 2 (MASP2) Exhibits Therapeutic Potential for Treatment of IgAN 2小时前